Patient-level data: A paradigm shift in clinical trial transparency?

Interventional Cardiology (London)

Volumn 5, Issue 6, 2013, Pages 619-621

  Lumley, Matthew ^a   Perera, Divaka ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

clinical trials; evidence based medicine; medical statistics; patient level data; pharmaceutical industry; trial methodology

Indexed keywords

CLINICAL TRIAL (TOPIC); DRUG INDUSTRY; EVIDENCE BASED PRACTICE; HUMAN; MEDICAL LITERATURE; NOTE; PRIORITY JOURNAL; PUBLICATION; REGISTER; TREATMENT OUTCOME;

EID: 84890353631     PISSN: 17555302     EISSN: 17555310     Source Type: Journal    
DOI: 10.2217/ica.13.71     Document Type: Note

References (21)

1. Song F, Parekh S, Hooper L et al. Dissemination and publication of research findings: An updated review of related biases. Health Technol. Assess. 14(8), iii, ix-xi, 1-193 (2010
2. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N. Engl. J. Med. 358(3), 252-260 (2008
3. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B. Evidence b(i)ased medicine - selective reporting from studies sponsored by pharmaceutical industry: Review of studies in new drug applications. BMJ326(7400), 1171-1173 (2003
4. McGauran N, Wieseler B, Kreis J, Schüler YB, Kölsch H, Kaiser T. Reporting bias in medical research - a narrative review. Trials 11, 37 (2010
5. Lee K, Bacchetti P, Sim I. Publication of clinical trials supporting successful new drug applications: A literature analysis. PLoS Med. 5(9), e191 (2008
6. Pich J, Carné X, Arnaiz JA, Gómez B, Trilla A, Rodés J. Role of a research ethics committee in follow-up and publication of results. Lancet 361(9362), 1015-1016 (2003
7. Stern JM, Simes RJ. Publication bias: Evidence of delayed publication in a cohort study of clinical research projects. BMJ 315(7109), 640-645 (1997
8. Dickersin K, Min YI, Meinert CL. Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. JAMA 267(3), 374-378 (1992
9. Blümle A, Antes G, Schumacher M, Just H, von Elm E. Clinical research projects at a German medical faculty: Follow-up from ethical approval to publication and citation by others. J. Med. Ethics 34(9), e20 (2008
10. Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles. JAMA 291(20), 2457-2465 (2004
11. Laine C, Horton R, De Angelis CD et al. Clinical trial registration: Looking back and moving ahead. JAMA 298(1), 93-94 (2007
12. Doshi P, Jefferson T, Del Mar C. The imperative to share clinical study reports: Recommendations from the Tamiflu experience. PLoS Med. 9(4), e1001201 (2012
13. Chan AW, Tetzlaff JM, Altman DG et al. SPIRIT 2013 statement: Defining standard protocol items for clinical trials. Ann. Intern. Med. 158(3), 200-207 (2013
14. Godlee F. Clinical trial data for all drugs in current use. BMJ 345, e7304 (2012
15. Gøtzsche PC, Jørgensen AW. Opening up data at the European medicines agency. BMJ 342, d2686 (2011
16. Doshi P, Jefferson T. The first 2 years of the European medicines agency's policy on access to documents: Secret no longer. JAMA Intern. Med. 173(5), 380-382 (2013
17. Eichler HG, Abadie E, Breckenridge A, Leufkens H, Rasi G. Open clinical trial data for all? A view from regulators. PLoS Med. 9(4), e1001202 (2012
18. Nisen P, Rockhold F. Access to patient-level data from glaxosmithkline clinical trials. N. Engl. J. Med. 475-478 (2013
19. Doshi P, Dickersin K, Healy D, Vedula SS, Jefferson T. Restoring invisible and abandoned trials: A call for people to publish the findings. BMJ 346, f2865 (2013
20. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N. Engl. J. Med. 345(7), 494-502 (2001
21. Sabatine MS, Cannon CP, Gibson CM et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N. Engl. J. Med. 352(12), 1179-1189 (2005